The role of tumor necrosis factor alpha G-308A polymorphisms in the course of pulmonary sarcoidosis

Tissue Antigens

Volumn 75, Issue 3, 2010, Pages 262-268

  Wijnen, P A ^a   Nelemans, P J ^b   Verschakelen, J A ^c   Bekers, O ^a   Voorter, C E ^a   Drent, M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Disease course; Sarcoidosis; Tumor necrosis factor alpha

Indexed keywords

CORTICOSTEROID; GENOMIC DNA; HLA DR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DISEASE COURSE; DNA EXTRACTION; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC LINKAGE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HLA TYPING; HUMAN; LUNG BIOPSY; LUNG FUNCTION TEST; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SARCOIDOSIS; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; THORAX RADIOGRAPHY;

ALLELES; CASE-CONTROL STUDIES; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HLA-DR ANTIGENS; HUMANS; LYMPHOTOXIN-ALPHA; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SARCOIDOSIS; SARCOIDOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA; X-RAYS;

EID: 76249084043     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2009.01437.x     Document Type: Article

References (36)

1. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999 : 160 : 736 755.
2. Moller DR, Chen ES. Genetic basis of remitting sarcoidosis: triumph of the trimolecular complex? Am J Respir Cell Mol Biol 2002 : 27 : 391 395.
3. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007 : 357 : 2153 2165.
4. Thomas KW, Hunninghake GW. Sarcoidosis. JAMA 2003 : 289 : 3300 3303.
5. Neville E, Walker AN, James DG. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med 1983 : 52 : 525 533.
6. Grunewald J, Eklund A, Olerup O. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am J Respir Crit Care Med 2004 : 169 : 696 702.
7. Mrazek F, Holla LI, Hutyrova B et al. Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Lofgren's syndrome in Czech patients with sarcoidosis. Tissue Antigens 2005 : 65 : 163 171.
8. Grutters JC, Sato H, Pantelidis P et al. Increased frequency of the uncommon tumor necrosis factor -857T allele in British and Dutch patients with sarcoidosis. Am J Respir Crit Care Med 2002 : 165 : 1119 1124.
9. Swider C, Schnittger L, Bogunia-Kubik K et al. TNF-alpha and HLA-DR genotyping as potential prognostic markers in pulmonary sarcoidosis. Eur Cytokine Netw 1999 : 10 : 143 146.
10. Baughman RP, Costabel U, du Bois RM. Treatment of sarcoidosis. Clin Chest Med 2008 : 29 : 533 548.
11. Seitzer U, Swider C, Stuber F et al. Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis. Cytokine 1997 : 9 : 787 790.
12. Voorter CE, Drent M, van den Berg-Loonen EM. Severe pulmonary sarcoidosis is strongly associated with the haplotype HLA-DQB1*0602- DRB1*150101. Hum Immunol 2005 : 66 : 826 835.
13. Bendtzen K, Morling N, Fomsgaard A et al. Association between HLA-DR2 and production of tumour necrosis factor alpha and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand J Immunol 1988 : 28 : 599 606.
14. Seitzer U, Gerdes J, Muller-Quernheim J. Genotyping in the MHC locus: potential for defining predictive markers in sarcoidosis. Respir Res 2002 : 3 : 6.
15. Iannuzzi MC. Advances in the genetics of sarcoidosis. Proc Am Thorac Soc 2007 : 4 : 457 460.
16. Sharma OP. Tumor necrosis factor polymorphism in sarcoidosis. Chest 2001 : 119 : 678 679.
17. Medica I, Kastrin A, Maver A et al. Role of genetic polymorphisms in ACE and TNF-alpha gene in sarcoidosis: a meta-analysis. J Hum Genet 2007 : 52 : 836 847.
18. Chinoy H, Salway F, John S et al. Tumour necrosis factor-alpha single nucleotide polymorphisms are not independent of HLA class I in UK Caucasians with adult onset idiopathic inflammatory myopathies. Rheumatology (Oxford) 2007 : 46 : 1411 1416.
19. Quanjer PH, Tammeling GJ, Cotes JE et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993 : 16 : 5 40.
20. Bestmann L, Helmy N, Garofalo F et al. LightCycler PCR for the polymorphisms -308 and -238 in the TNF alpha gene and for the TNFB1/B2 polymorphisms in the LT alpha gene. In: Dietmaier W, Wittwer C, Sivasubramanian N, eds. Rapid Cycle Real-Time PCR - Methods and Applications Genetics and Oncology. Berlin : Springer-Verlag, 2002, 95 105.
21. Castro-Giner F, Kogevinas M, Machler M et al. TNFA-308G>A in two international population-based cohorts and risk of asthma. Eur Respir J 2008 : 32 : 350 361.
22. Voorter CE, Rozemuller EH, de Bruyn-Geraets D et al. Comparison of DRB sequence-based typing using different strategies. Tissue Antigens 1997 : 49 : 471 476.
23. Bouma G, Xia B, Crusius JB et al. Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin Exp Immunol 1996 : 103 : 391 396.
24. Schaaf BM, Seitzer U, Pravica V et al. Tumor necrosis factor-alpha -308 promoter gene polymorphism and increased tumor necrosis factor serum bioactivity in farmer's lung patients. Am J Respir Crit Care Med 2001 : 163 : 379 382.
25. Sharma S, Ghosh B, Sharma SK. Association of TNF polymorphisms with sarcoidosis, its prognosis and tumour necrosis factor (TNF)-alpha levels in Asian Indians. Clin Exp Immunol 2008 : 151 : 251 259.
26. Yamaguchi E, Itoh A, Hizawa N et al. The gene polymorphism of tumor necrosis factor-beta, but not that of tumor necrosis factor-alpha, is associated with the prognosis of sarcoidosis. Chest 2001 : 119 : 753 761.
27. Hance AJ, Basset F, Saumon G et al. Smoking and interstitial lung disease. The effect of cigarette smoking on the incidence of pulmonary histiocytosis X and sarcoidosis. Ann N Y Acad Sci 1986 : 465 : 643 656.
28. Maier LA. Is smoking beneficial for granulomatous lung diseases? Am J Respir Crit Care Med 2004 : 169 : 893 895.
29. Blanchet MR, Israel-Assayag E, Cormier Y. Inhibitory effect of nicotine on experimental hypersensitivity pneumonitis in vivo and in vitro. Am J Respir Crit Care Med 2004 : 169 : 903 909.
30. Valeyre D, Soler P, Clerici C et al. Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax 1988 : 43 : 516 524.
31. Drent M, Bomans PH, Van Suylen RJ et al. Association of man-made mineral fibre exposure and sarcoid like granulomas. Respir Med 2000 : 94 : 815 820.
32. Barnard J, Rose C, Newman L et al. Job and industry classifications associated with sarcoidosis in A Case-Control Etiologic Study of Sarcoidosis (ACCESS). J Occup Environ Med 2005 : 47 : 226 234.
33. Baughman RP. Pulmonary sarcoidosis. Clin Chest Med 2004 : 25 : 521 530, vi
34. Baughman RP, Lower EE, Drent M. Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: who, what, and how to use them. Sarcoidosis Vasc Diffuse Lung Dis 2008 : 25 : 76 89.
35. Mugnier B, Balandraud N, Darque A et al. Polymorphism at position -308 of the tumor necrosis factor alpha gene influences outcome of infliximab therapy in rheumatoid arthritis. Arthritis Rheum 2003 : 48 : 1849 1852.
36. Baughman RP, Drent M, Kavuru M et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 2006 : 174 : 795 802.